Applied Clinical Trials-06-01-2022

Tech companies entering space must adapt and adhere to regulations set by FDA.

COVID has accelerated to the scene upstart digital efforts to transform patient engagement and data management/integration—but progress remains measured.

Study uncovers pre-pandemic deviation levels.

Pandemic aside, remote solutions are advancing care in clinical trials.

Martin Gouldstone, Global SVP, business development, Owkin, speaks to ACT on the use of AI in data practices and approaches for clinical research, and the distinction of “ethical AI."

Pandemic trends set stage for upcoming DIA Global Annual Meeting.

Click the title above for a link to open the Applied Clinical Trials June 2022 issue in an interactive PDF format.

ICH draft guidance proposes standardized framework for identifying ways development programs for adult treatments can inform pediatric studies.

Just-released analysis by Prescrire contends that the agency “is backtracking on commitments to clinical data transparency.”

Series Part 1—Introduction and the relationship between QTL and KRI.

Industry must act now to minimize effects of COVID-19 on clinical research.